Related Experiment Video
Updated: May 4, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
9.9K
Behçet's syndrome pathophysiology and potential therapeutic targets
Giacomo Emmi1, Elena Silvestri, Danilo Squatrito
1Department of Experimental and Clinical Medicine, University of Florence, L.go G. Brambilla 3, 50134, Florence, Italy, giacomaci@yahoo.it.
Internal and Emergency Medicine
|January 14, 2014
Summary
Behçet syndrome is a complex inflammatory disease affecting multiple organs. Understanding its immune dysregulation and genetic/environmental factors may reveal new therapeutic targets.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Behçet syndrome is a systemic inflammatory disorder with diverse organ involvement, including mucocutaneous, ocular, neurological, and vascular manifestations.
- The exact pathogenetic mechanisms remain incompletely understood, but involve immune dysregulation influenced by genetic predisposition and environmental factors.
Purpose of the Study:
- To review the potential pathogenetic mechanisms of Behçet syndrome.
- To identify novel therapeutic targets based on emerging immunological pathways.
Main Methods:
- This is a review article, synthesizing current knowledge on Behçet syndrome pathogenesis.
- Literature search and analysis of immunological pathways implicated in the disease.
Main Results:
- The review focuses on the interplay between genetic background and environmental triggers in driving immune dysregulation in Behçet syndrome.
- Several immunological pathways are discussed as potential contributors to disease development.
Conclusions:
- Further research into the immunological underpinnings of Behçet syndrome is crucial for developing targeted therapies.
- Identifying specific immunological pathways offers promising avenues for novel treatment strategies.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
02:26NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:25Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35